BLINCYTO vs SPRYCEL

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 11, 2026·How we rate

Possible drug interaction. BLINCYTO and SPRYCEL are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BLINCYTO	SPRYCEL
Rating	72/100	72/100
Pharmacy pays	—	~$839.19 /30
Type	RX	RX
Active ingredient	BLINATUMOMAB	DASATINIB
Manufacturer	Amgen Inc	Bristol Myers Squibb
Dosage forms	Kit	Tablet
Drug class	—	Kinase Inhibitor
Boxed warning	Boxed warning	None
Treats	Lymphoid Leukemia	Lymphoid Leukemia, Myeloid Leukemia

blincyto sprycel

Rating

72/100

Pharmacy pays

—

~$839.19 /30

Type

Active ingredient

BLINATUMOMAB

DASATINIB

Manufacturer

Amgen Inc

Bristol Myers Squibb

Dosage forms

Kit

Tablet

Drug class

—

Kinase Inhibitor

Boxed warning

None

Treats

Lymphoid Leukemia

Lymphoid Leukemia, Myeloid Leukemia

Frequently asked questions

Which is better-rated, Blincyto or Sprycel?

Blincyto and Sprycel are tied at 3.6 out of 5 by our independent rating.

What is the difference between Blincyto and Sprycel?

Blincyto contains Blinatumomab, while Sprycel contains Dasatinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.